ATE404580T1 - Sulfonylamino-peptidomimetika, die auf die somatostatinrezeptor-subtypen 4 (sstr4) und 1 (sstr1) wirken - Google Patents
Sulfonylamino-peptidomimetika, die auf die somatostatinrezeptor-subtypen 4 (sstr4) und 1 (sstr1) wirkenInfo
- Publication number
- ATE404580T1 ATE404580T1 AT04767097T AT04767097T ATE404580T1 AT E404580 T1 ATE404580 T1 AT E404580T1 AT 04767097 T AT04767097 T AT 04767097T AT 04767097 T AT04767097 T AT 04767097T AT E404580 T1 ATE404580 T1 AT E404580T1
- Authority
- AT
- Austria
- Prior art keywords
- sstr4
- somatostatin receptor
- sstr1
- peptidomimetics
- sulfonylamino
- Prior art date
Links
- 108050001286 Somatostatin Receptor Proteins 0.000 title abstract 3
- 102000011096 Somatostatin receptor Human genes 0.000 title abstract 3
- -1 SULFONYLAMINO Chemical class 0.000 title abstract 2
- 239000000816 peptidomimetic Substances 0.000 title abstract 2
- 102100023801 Somatostatin receptor type 4 Human genes 0.000 abstract 2
- 108010064556 somatostatin receptor subtype-4 Proteins 0.000 abstract 2
- 102100029329 Somatostatin receptor type 1 Human genes 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 108010082379 somatostatin receptor type 1 Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- C07K5/06095—Arg-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50827003P | 2003-10-06 | 2003-10-06 | |
| FI20031455A FI20031455A0 (fi) | 2003-10-06 | 2003-10-06 | Sulfonyyliamino-peptidomimeettejä, jotka ovat aktiivisia somatostatiinireseptorialatyyppien 4 (SSTR4) ja 1 (SSTR1) suhteen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE404580T1 true ATE404580T1 (de) | 2008-08-15 |
Family
ID=29225904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04767097T ATE404580T1 (de) | 2003-10-06 | 2004-10-05 | Sulfonylamino-peptidomimetika, die auf die somatostatinrezeptor-subtypen 4 (sstr4) und 1 (sstr1) wirken |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20070129313A1 (enExample) |
| EP (1) | EP1678196B1 (enExample) |
| JP (1) | JP2007507472A (enExample) |
| AT (1) | ATE404580T1 (enExample) |
| FI (1) | FI20031455A0 (enExample) |
| WO (1) | WO2005033124A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20031454A0 (fi) * | 2003-10-06 | 2003-10-06 | Juvantia Pharma Ltd Oy | Selektiivisiä somatostatiinireseptori 1 ja/tai 4 -agonisteja ja -antagonisteja |
| US20100004339A1 (en) * | 2003-10-06 | 2010-01-07 | Oy Juvantia Pharma Ltd. | Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists |
| WO2005082844A1 (en) * | 2004-02-27 | 2005-09-09 | Oy Juvantia Pharma Ltd | Treatment of diseases by using a somatostatin receptor agonist |
| WO2005082845A1 (en) * | 2004-02-27 | 2005-09-09 | Oy Juvantia Pharma Ltd | Novel therapies with somatostatin receptor agonists |
| WO2006123020A1 (en) * | 2005-05-18 | 2006-11-23 | Juvantia Pharma Ltd Oy | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 |
| US11912687B2 (en) | 2017-05-12 | 2024-02-27 | Board of Trustees of the Southern Illinois University | 3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof |
| EP3634406B1 (en) | 2017-05-12 | 2023-09-06 | Board of Trustees of The Southern Illinois University on behalf of Southern Illinois University Edwardsville | 3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof |
| JP7099717B2 (ja) * | 2019-09-30 | 2022-07-12 | 株式会社理研バイオ | ソマトスタチン受容体 |
| AR121683A1 (es) * | 2020-03-31 | 2022-06-29 | Takeda Pharmaceuticals Co | Derivados de n-heteroarilalquil-2-(heterociclil y heterociclilmetil)acetamida como agonistas de sstr4 |
| WO2025247982A1 (en) | 2024-05-29 | 2025-12-04 | Grünenthal GmbH | Piperazines which act as sstr4 modulators |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20040007565A (ko) * | 2001-05-15 | 2004-01-24 | 다이쇼 세이야꾸 가부시끼가이샤 | 아르기닌 유도체 |
| WO2003026657A1 (en) * | 2001-09-24 | 2003-04-03 | Synaptic Pharmaceutical Corporation | Compounds for the treatment of pain |
| WO2003026575A2 (en) * | 2001-09-24 | 2003-04-03 | Synaptic Pharmaceutical Corporation | Molecules specific for npff receptors and uses thereof |
| JP2004155695A (ja) * | 2002-11-06 | 2004-06-03 | Taisho Pharmaceut Co Ltd | Ｍｃ４受容体に対するリガンド |
| FI20031454A0 (fi) * | 2003-10-06 | 2003-10-06 | Juvantia Pharma Ltd Oy | Selektiivisiä somatostatiinireseptori 1 ja/tai 4 -agonisteja ja -antagonisteja |
-
2003
- 2003-10-06 FI FI20031455A patent/FI20031455A0/fi not_active Application Discontinuation
-
2004
- 2004-10-05 AT AT04767097T patent/ATE404580T1/de not_active IP Right Cessation
- 2004-10-05 WO PCT/FI2004/000583 patent/WO2005033124A1/en not_active Ceased
- 2004-10-05 US US10/574,905 patent/US20070129313A1/en not_active Abandoned
- 2004-10-05 JP JP2006530316A patent/JP2007507472A/ja active Pending
- 2004-10-05 EP EP04767097A patent/EP1678196B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20070129313A1 (en) | 2007-06-07 |
| EP1678196B1 (en) | 2008-08-13 |
| EP1678196A1 (en) | 2006-07-12 |
| JP2007507472A (ja) | 2007-03-29 |
| FI20031455A0 (fi) | 2003-10-06 |
| WO2005033124A1 (en) | 2005-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA04004741A (es) | Derivados de tiazol que tienen actividad antagonista, agonista o agonista parcial alcanabinoide1. | |
| DK1337518T3 (da) | Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren | |
| DE60222396D1 (de) | N-(2-arylethyl) benzylamine als 5-ht6 rezeptor-antagoniste | |
| ZA201102735B (en) | Antagonists of the vanilloid receptor subtype 1(vr1) and uses thereof | |
| SG163585A1 (en) | Melanocortin receptor ligands | |
| TW200637550A (en) | Thiazole-4-carboxamide derivatives as mGluR5 antagonists | |
| MXPA05013474A (es) | Derivados de quinolilamida como antagonistas de ccr-5. | |
| ATE374190T1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
| EA200700047A1 (ru) | Новые алкильные производные в качестве метаботропных рецепторов глутамата | |
| FI20031455A0 (fi) | Sulfonyyliamino-peptidomimeettejä, jotka ovat aktiivisia somatostatiinireseptorialatyyppien 4 (SSTR4) ja 1 (SSTR1) suhteen | |
| MXPA05013149A (es) | Derivados de imidazol como antagonistas del receptor de glutamato. | |
| CO5460266A1 (es) | Novedosos analogos de la somatostatina | |
| ATE411287T1 (de) | Neue metallproteinaseinhibitoren | |
| EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
| DK1644389T3 (da) | Pyrinidinforbindelser med phosphonatgrupper som antivirale nukleotidanaloger | |
| MXPA05005198A (es) | Derivados de imidazoquinolina, como ligandos del receptor a3 de adenosina. | |
| ATE482931T1 (de) | Somatostatinrezeptor-1- und/oder -4-selektive agonisten und antagonisten | |
| EA200700997A1 (ru) | 2,5- и 2,6-дизамещенные аналоги бензазола, полезные в качестве ингибиторов протеинкиназ | |
| DE602004016328D1 (de) | 2-imidazo-benzothiazole als adenosin-rezeptor liganden | |
| TW200610764A (en) | Novel quinoline thiazolinones | |
| MX2007004661A (es) | Derivados de 1-(hetero)aril-3-amino-pirrolidina para usarse como antagonistas del receptor mglur3. | |
| ATE390427T1 (de) | Diazabicylononan - und decanderivate und ihre verwendung als opioid-rezeptorligande | |
| MXPA05006587A (es) | Compuestos de tiazol como derivados de antagonistas del receptor de la integrina. | |
| MXPA05012279A (es) | Derivados de bencil sulfonamida. | |
| SE0303419D0 (sv) | New use 11 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |